Lemus David
SEC insider (Form 3/4/5 filer). CIK 0001717972. Director at Silence Therapeutics plc (SLN) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in LONDON, X0.
Companies Lemus David has filed insider reports for
- Silence Therapeutics plc (SLN): Director
- Scilex Holding Co (SCLX): Director
Lemus David
CIK: 0001717972
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
